News

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
The boss of the drugs giant behind Ozempic has quit after falling behind in the global race to develop weight-loss medication ...
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...